Simplex Trading’s Entera Bio ENTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.8K Buy
+15,698
New +$19.6K ﹤0.01% 6820
2025
Q4
Sell
-69
Closed 8922
2025
Q3
$0 Buy
+69
New +$132 ﹤0.01% 9292
2024
Q3
Sell
-260
Closed -$461 8755
2024
Q2
$0 Sell
260
-35
-12% -$77 ﹤0.01% 9027
2024
Q1
$0 Buy
+295
New +$326 ﹤0.01% 9091
2023
Q4
Sell
-86
Closed -$59 9032
2023
Q3
$0 Sell
86
-13
-13% -$10 ﹤0.01% 8939
2023
Q2
$0 Buy
+99
New +$85 ﹤0.01% 9206
2022
Q2
Sell
-230
Closed -$511 10206
2022
Q1
$0 Sell
230
-682
-75% -$1.64K ﹤0.01% 10626
2021
Q4
$2K Sell
912
-18,529
-95% -$69.4K ﹤0.01% 9975
2021
Q3
$122K Buy
19,441
+3,699
+23% +$19K ﹤0.01% 6332
2021
Q2
$94K Buy
+15,742
New +$58.2K ﹤0.01% 6820

Other funds holding ENTX

Simplex Trading's ENTX Position: Q2 2026 in Review

Simplex Trading opened a new position in Entera Bio (ENTX) in Q2 2026: 15,698 shares worth $27.8K. The stake represents ﹤0.01% of the portfolio and ranks #6820 among its holdings. This is a return to the name: Simplex Trading previously reported a position in ENTX as recently as Q3 2025.

Simplex Trading first reported a position in ENTX in Q2 2021 and has held it in 10 quarters since. The position peaked at $122K in Q3 2021. 27 funds tracked by Wall St. Rank hold ENTX as of Q2 2026.

  • Simplex Trading held 15,698 shares of Entera Bio worth $27.8K as of Q2 2026.
  • Entera Bio was a new Simplex Trading position in Q2 2026.
  • Entera Bio made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #6820 holding.
  • Simplex Trading first reported a position in Entera Bio in Q2 2021 and has held it in 10 quarters since.
  • Simplex Trading's Entera Bio position peaked at $122K in Q3 2021.
  • 27 funds tracked by Wall St. Rank held Entera Bio as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.